2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl ]methyl]thio]-N-[4-(trifluoromethoxy) phenyl]-3-pyridinecarboxamide benzenesulfonate, crystals of same, polymorphs thereof, and processes for production thereof

Details for Australian Patent Application No. 2010271746 (hide)

Owner Santen Pharmaceutical Co., Ltd.

Inventors Niwa, Masashi; Deguchi, Hiroshi

Agent Davies Collison Cave

Pub. Number AU-A-2010271746

PCT Pub. Number WO2011/007870

Priority 2009-169130 17.07.09 JP

Filing date 16 July 2010

Wipo publication date 20 January 2011

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/007870 Priority application(s): WO2011/007870

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010271763-Micro glass bead retroreflection sheet equipped with images having visual recognition directionality

2010271732-Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer